Compare Indoco Remedies with THOMAS COOK INDIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs THOMAS COOK INDIA - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

THOMAS COOK INDIA 
   Change

Thomas Cook India (TCIL) offers a broad spectrum of leisure travel related services such as package tours, currency exchange and travel insurance as well as hotel and flight reservations. TCIL has been present in India for 128 years. In 2006, the com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES THOMAS COOK INDIA INDOCO REMEDIES/
THOMAS COOK INDIA
 
P/E (TTM) x 127.4 -450.8 - View Chart
P/BV x 2.1 0.6 330.3% View Chart
Dividend Yield % 0.6 0.3 254.7%  

Financials

 INDOCO REMEDIES   THOMAS COOK INDIA
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
THOMAS COOK INDIA
Mar-18
INDOCO REMEDIES/
THOMAS COOK INDIA
5-Yr Chart
Click to enlarge
High Rs317292 108.7%   
Low Rs178202 88.1%   
Sales per share (Unadj.) Rs113.1303.8 37.2%  
Earnings per share (Unadj.) Rs4.5165.6 2.7%  
Cash flow per share (Unadj.) Rs11.8169.3 7.0%  
Dividends per share (Unadj.) Rs1.000.38 263.2%  
Dividend yield (eoy) %0.40.2 262.4%  
Book value per share (Unadj.) Rs73.2234.2 31.3%  
Shares outstanding (eoy) m92.15370.21 24.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.20.8 269.5%   
Avg P/E ratio x55.51.5 3,719.2%  
P/CF ratio (eoy) x21.01.5 1,437.5%  
Price / Book Value ratio x3.41.1 320.7%  
Dividend payout %22.40.2 9,757.7%   
Avg Mkt Cap Rs m22,83091,442 25.0%   
No. of employees `0005.52.4 225.2%   
Total wages/salary Rs m2,20953,022 4.2%   
Avg. sales/employee Rs Th1,910.146,442.4 4.1%   
Avg. wages/employee Rs Th405.021,891.9 1.8%   
Avg. net profit/employee Rs Th75.525,315.4 0.3%   
INCOME DATA
Net Sales Rs m10,419112,483 9.3%  
Other income Rs m471,338 3.5%   
Total revenues Rs m10,466113,822 9.2%   
Gross profit Rs m1,3494,005 33.7%  
Depreciation Rs m6771,367 49.5%   
Interest Rs m2351,490 15.8%   
Profit before tax Rs m4842,487 19.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0167 0.0%   
Extraordinary Inc (Exp) Rs m058,255 0.0%   
Tax Rs m72-406 -17.9%   
Profit after tax Rs m41261,314 0.7%  
Gross profit margin %12.93.6 363.7%  
Effective tax rate %15.0-16.3 -91.7%   
Net profit margin %4.054.5 7.2%  
BALANCE SHEET DATA
Current assets Rs m5,37328,926 18.6%   
Current liabilities Rs m4,15728,153 14.8%   
Net working cap to sales %11.70.7 1,698.4%  
Current ratio x1.31.0 125.8%  
Inventory Days Days680 191,527.3%  
Debtors Days Days7328 261.7%  
Net fixed assets Rs m6,24417,362 36.0%   
Share capital Rs m184370 49.8%   
"Free" reserves Rs m6,56686,339 7.6%   
Net worth Rs m6,75086,709 7.8%   
Long term debt Rs m1,2332,310 53.4%   
Total assets Rs m12,363122,042 10.1%  
Interest coverage x3.12.7 114.6%   
Debt to equity ratio x0.20 685.6%  
Sales to assets ratio x0.80.9 91.4%   
Return on assets %5.251.5 10.2%  
Return on equity %6.170.7 8.6%  
Return on capital %9.070.1 12.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,762388 968.7%   
Fx outflow Rs m1,143139 825.6%   
Net fx Rs m2,619250 1,048.0%   
CASH FLOW
From Operations Rs m1,227-2,442 -50.2%  
From Investments Rs m-1,360-999 136.1%  
From Financial Activity Rs m-3884,767 -8.1%  
Net Cashflow Rs m-521-2,254 23.1%  

Share Holding

Indian Promoters % 59.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 12.5 0.2 6,250.0%  
FIIs % 6.0 12.4 48.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 12.4 180.6%  
Shareholders   12,805 34,019 37.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   ADANI PORTS & SEZ  KITEX GARMENTS  TIMKEN INDIA  FINOLEX INDUSTRIES  S.P. APPARELS  



Today's Market

Indian Indices Extend Rally; Sensex Zooms 1,250 Points(12:30 pm)

Share markets in India are presently trading on a strong note, cheering the government's move to cut corporate tax rates to boost economic growth.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

THOMAS COOK INDIA Announces Quarterly Results (1QFY20); Net Profit Down 74.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, THOMAS COOK INDIA has posted a net profit of Rs 164 m (down 74.6% YoY). Sales on the other hand came in at Rs 23 bn (up 11.2% YoY). Read on for a complete analysis of THOMAS COOK INDIA's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

THOMAS COOK INDIA Announces Quarterly Results (4QFY19); Net Profit Down 125.9% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, THOMAS COOK INDIA has posted a net profit of Rs 193 m (down 125.9% YoY). Sales on the other hand came in at Rs 14 bn (down 47.0% YoY). Read on for a complete analysis of THOMAS COOK INDIA's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 23, 2019 03:03 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS